Informed Investing
Subscribe
NewsArticlesLearnPodcastSubscribe

#ETF investment

NewsArticlesLearnPodcast
History Says This ETF Is a Fantastic Buy-and-Hold Investment -- and It Could Turn $100 per Month Into $359,492 | The Motley Fool
NOVEMBER 8, 2026

History Says This ETF Is a Fantastic Buy-and-Hold Investment -- and It Could Turn $100 per Month Into $359,492 | The Motley Fool

High-yield dividend stocks, while often perceived as safer than tech stocks, typically offer slower growth. For professionals seeking diversification away from AI stocks, the Schwab U.S. Dividend Equity ETF (SCHD) presents an attractive option, holding 102 large-cap companies with a low expense ratio of 0.06%. With a 15-year...


Read More >
If I Could Invest $1,000 in Just 1 ETF in August, I'd Pick This Clear Standout Over the Vanguard S&P 500 ETF (VOO) | The Motley Fool
AUGUST 14, 2026

If I Could Invest $1,000 in Just 1 ETF in August, I'd Pick This Clear Standout Over the Vanguard S&P 500 ETF (VOO) | The Motley Fool

The Vanguard S&P 500 ETF has made headlines as the first ETF to exceed $1 trillion in assets, thanks to its low expense ratio of 0.03%. However, for those seeking a more balanced investment, the Vanguard Communication Services ETF (VOX) may be a better choice. With a slightly higher expense ratio of 0.09%, VOX offers exposure...


Read More >
Informed Investing
About UsContact
PrivacyTermsCopyright

Informed Investing is for informational and educational purposes only and is not financial, investment, tax, or legal advice. Nothing on this site constitutes a recommendation, solicitation, or offer to buy or sell any security or financial product. Investing involves risk, including loss of principal. Content may be developed with the assistance of analytical and automated tools, including AI systems, and is subject to human editorial review. Information may be incomplete, inaccurate, or outdated. You should independently verify information before acting on it and consult a qualified professional as appropriate.

© 2026 Informed Investing. All rights reserved.